Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EMCURE PHARMACEUTICALS LTD. Gains 8%; BSE HEALTHCARE Index Down 0.5%
Tue, 26 Nov 10:30

EMCURE PHARMACEUTICALS LTD. Gains 8%; BSE HEALTHCARE Index Down 0.5%Image source: hudiemm/www.istockphoto.com

EMCURE PHARMACEUTICALS LTD. share price has zoomed 8% and is presently trading at Rs 1,408.0.

Meanwhile, the BSE HEALTHCARE index is at 43,178.6 (down 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (up 2.3%) and CAPLIN POINT (up 2.3%).

POLY MEDICURE (down 7.5%) and FORTIS HEALTHCARE (down 2.4%) are among the top losers today.

Over the last one year, EMCURE PHARMACEUTICALS LTD. has moved up from Rs 0.0 to Rs 1,408.0, registering a gain of Rs 1,408.0 .

On the other hand, the BSE HEALTHCARE index has moved up from 29,918.9 to 43,178.6, registering a gain of 44.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 164.1%), SUVEN PHARMACEUTICALS (up 110.1%) and Glenmark Pharma (up 93.4%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,955.6 (down 0.2%).

The top losers among the BSE Sensex today are Ultratech Cement (down 2.3%) and MUNDRA PORT & SEZ (down 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,201.3 (down 0.1%). Ultratech Cement and Adani Enterprises are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.2 to 79,955.6, registering a gain of 13,932.3 points (up 21.1%).

EMCURE PHARMACEUTICALS LTD. Financial Update...

EMCURE PHARMACEUTICALS LTD. net profit fell {profitpercent} YoY to Rs 2,015 million for the quarter ended September 2024, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 20,020 million during the period as against Rs {salesnumberprev} million in {quarterprev}.

For the year ended March 2024, EMCURE PHARMACEUTICALS LTD. reported 6.1% decrease in net profit to Rs 5,276 million compared to net profit of Rs 5,618 million during FY23. Revenue of the company grew 11.2% to Rs 66,583 million during FY24.


Equitymaster requests your view! Post a comment on "EMCURE PHARMACEUTICALS LTD. Gains 8%; BSE HEALTHCARE Index Down 0.5%". Click here!